• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿奇霉素和头孢曲松在 LPS 预刺激的癌细胞中差异激活 NLRP3。

Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

机构信息

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Department of Fundamental Sciences, Faculty of Dentistry, Bursa Uludag University, Bursa 16059, Turkey.

出版信息

Int J Mol Sci. 2022 Aug 22;23(16):9484. doi: 10.3390/ijms23169484.

DOI:10.3390/ijms23169484
PMID:36012769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409354/
Abstract

BACKGROUND

Cancer patients are prescribed antibiotics, such as macrolides and lactamides, for infection treatment. However, the effect of these antibiotics on NLRP3 activation remains largely unknown.

METHOD

Lung cancer (A549) and prostate cancer (PC3) cell lines were primed with lipopolysaccharide (LPS) to activate NLRP3 transcription. Cells were then treated with azithromycin (Az) or ceftriaxone (Cf). NLRP3 activation was analyzed by qPCR, Western blot, and ELISA. Cell growth and viability were assessed by real-time cell analysis and Annexin V expression. Levels of 41 cytokines were also analyzed using a multiplex assay.

RESULTS

LPS-Az activated transcription of , , and in A549 cells, while failing to upregulate and in PC3 cells. LPS-Az decreased the secretion of pro-inflammatory cytokines while it induced the pro-angiogenic factors in A549 and PC3 cells. In contrast, LPS-Cf suppressed the expression of NLRP3-associated genes, NLRP3 protein expression, the inflammatory cytokine secretion in A549 and PC3 cells. LPS-Az and LPS-Cf had a limited effect on cell growth and viability.

DISCUSSION

Our data suggest that Cf could suppress LPS induced NLRP3, which should be considered when selecting antibiotics for cancer treatment. In contrast, the effect of Az on LPS primed NLRP3 and the inflammatory cytokines production appears to depend on the cancer cell origin. Therefore, these data indicate that considerations are required when selecting Az for the treatment of cancer patients.

摘要

背景

癌症患者常因感染而接受抗生素(如大环内酯类和头孢菌素类)治疗。然而,这些抗生素对 NLRP3 激活的影响在很大程度上仍不清楚。

方法

用脂多糖(LPS)预刺激肺癌(A549)和前列腺癌(PC3)细胞系以激活 NLRP3 转录。然后用阿奇霉素(Az)或头孢曲松(Cf)处理细胞。通过 qPCR、Western blot 和 ELISA 分析 NLRP3 激活。通过实时细胞分析和 Annexin V 表达评估细胞生长和活力。使用多重分析测定法还分析了 41 种细胞因子的水平。

结果

LPS-Az 激活了 A549 细胞中 、 和 的转录,但未能上调 PC3 细胞中的 和 。LPS-Az 降低了促炎细胞因子的分泌,同时诱导了 A549 和 PC3 细胞中的促血管生成因子。相比之下,LPS-Cf 抑制了 NLRP3 相关基因、NLRP3 蛋白表达以及 A549 和 PC3 细胞中炎症细胞因子的分泌。LPS-Az 和 LPS-Cf 对细胞生长和活力的影响有限。

讨论

我们的数据表明,Cf 可抑制 LPS 诱导的 NLRP3,在为癌症治疗选择抗生素时应考虑这一点。相比之下,Az 对 LPS 预刺激的 NLRP3 和炎症细胞因子产生的影响似乎取决于癌细胞的来源。因此,这些数据表明在为癌症患者选择 Az 进行治疗时需要考虑这些因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/b3aa1034dd11/ijms-23-09484-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/5c276ba54649/ijms-23-09484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/346c33021794/ijms-23-09484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/194ee8903b57/ijms-23-09484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/3e96ab7f5b1b/ijms-23-09484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/2f5efcf9ac72/ijms-23-09484-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/565dc9dd9e1c/ijms-23-09484-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/b3aa1034dd11/ijms-23-09484-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/5c276ba54649/ijms-23-09484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/346c33021794/ijms-23-09484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/194ee8903b57/ijms-23-09484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/3e96ab7f5b1b/ijms-23-09484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/2f5efcf9ac72/ijms-23-09484-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/565dc9dd9e1c/ijms-23-09484-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc10/9409354/b3aa1034dd11/ijms-23-09484-g007.jpg

相似文献

1
Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.阿奇霉素和头孢曲松在 LPS 预刺激的癌细胞中差异激活 NLRP3。
Int J Mol Sci. 2022 Aug 22;23(16):9484. doi: 10.3390/ijms23169484.
2
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.药理学靶向NLRP3炎性小体复合物在癌症中的治疗潜力
Front Immunol. 2021 Feb 3;11:607881. doi: 10.3389/fimmu.2020.607881. eCollection 2020.
3
Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.芦荟下调脂多糖诱导的人巨噬细胞中炎症细胞因子的产生和 NLRP3 炎性体的表达。
Mol Immunol. 2013 Dec;56(4):471-9. doi: 10.1016/j.molimm.2013.05.005. Epub 2013 Aug 1.
4
Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model.脂多糖 (LPS) 刺激胰腺导管腺癌 (PDAC) 和巨噬细胞激活 NLRP3 炎性体,影响共培养模型中促炎细胞因子的水平。
Cancer Biol Ther. 2023 Dec 31;24(1):2284857. doi: 10.1080/15384047.2023.2284857. Epub 2023 Nov 29.
5
BC-1215 inhibits ATP-induced IL-1β secretion via the FBXL2-mediated ubiquitination and degradation of not only NLRP3, but also pro-IL-1β in LPS-primed THP-1 cells.在脂多糖预处理的THP-1细胞中,BC-1215通过FBXL2介导的泛素化和降解作用,不仅抑制NLRP3,还抑制前白细胞介素-1β,从而抑制三磷酸腺苷诱导的白细胞介素-1β分泌。
Biochem Biophys Res Commun. 2023 May 21;657:128-135. doi: 10.1016/j.bbrc.2023.03.055. Epub 2023 Mar 22.
6
Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.6-、8-和 10-姜酚/姜酮对经典 NLRP3 炎性小体介导的 IL-1β 分泌的抑制能力比较。
Molecules. 2018 Feb 21;23(2):466. doi: 10.3390/molecules23020466.
7
Naloxone inhibits nod-like receptor protein 3 inflammasome.纳洛酮抑制NOD样受体蛋白3炎性小体。
J Surg Res. 2017 Nov;219:72-77. doi: 10.1016/j.jss.2017.05.119. Epub 2017 Jun 23.
8
The Overexpression of Sirtuin1 (SIRT1) Alleviated Lipopolysaccharide (LPS)-Induced Acute Kidney Injury (AKI) via Inhibiting the Activation of Nucleotide-Binding Oligomerization Domain-Like Receptors (NLR) Family Pyrin Domain Containing 3 (NLRP3) Inflammasome.Sirtuin1(SIRT1)的过表达通过抑制核苷酸结合寡聚结构域样受体(NLR)家族含 pyrin 结构域 3(NLRP3)炎性小体的激活缓解脂多糖(LPS)诱导的急性肾损伤(AKI)。
Med Sci Monit. 2019 Apr 13;25:2718-2726. doi: 10.12659/MSM.913146.
9
Leptin is upregulated in epididymitis and promotes apoptosis and IL-1β production in epididymal epithelial cells by activating the NLRP3 inflammasome.瘦素在附睾炎中上调,并通过激活NLRP3炎性小体促进附睾上皮细胞的凋亡和白细胞介素-1β的产生。
Int Immunopharmacol. 2020 Nov;88:106901. doi: 10.1016/j.intimp.2020.106901. Epub 2020 Sep 10.
10
Estradiol inhibits NLRP3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate.雌二醇抑制脂多糖和三磷酸腺苷激活的成纤维细胞样滑膜细胞中的NLRP3炎性小体。
Int J Rheum Dis. 2018 Nov;21(11):2002-2010. doi: 10.1111/1756-185X.13198. Epub 2017 Nov 3.

引用本文的文献

1
The role and mechanism of lung microbiota in coal mine dust-induced NLRP3 inflammasome upregulate and lung injury.肺微生物群在煤矿粉尘诱导NLRP3炎性小体上调及肺损伤中的作用和机制
Sci Rep. 2025 Jul 2;15(1):22990. doi: 10.1038/s41598-025-06411-0.

本文引用的文献

1
Infections in Cancer Patients.癌症患者的感染
Pathogens. 2022 Jun 12;11(6):679. doi: 10.3390/pathogens11060679.
2
Inflammasomes in Cancer Progression and Anti-Tumor Immunity.炎症小体在癌症进展和抗肿瘤免疫中的作用
Front Cell Dev Biol. 2022 Apr 20;10:839041. doi: 10.3389/fcell.2022.839041. eCollection 2022.
3
Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation.强力霉素通过抑制NLRP3介导的炎症来减弱癌细胞生长。
Pharmaceuticals (Basel). 2021 Aug 26;14(9):852. doi: 10.3390/ph14090852.
4
Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics.线粒体功能障碍作为 NLRP3 炎性体激活的驱动因素,以及通过线粒体自噬对其进行调节以作为潜在治疗方法。
Int J Biochem Cell Biol. 2021 Jul;136:106013. doi: 10.1016/j.biocel.2021.106013. Epub 2021 May 19.
5
G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.G-CSF 与肿瘤:侵袭性、肿瘤微环境与免疫细胞调控。
Cytokine. 2021 Jun;142:155479. doi: 10.1016/j.cyto.2021.155479. Epub 2021 Mar 4.
6
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.药理学靶向NLRP3炎性小体复合物在癌症中的治疗潜力
Front Immunol. 2021 Feb 3;11:607881. doi: 10.3389/fimmu.2020.607881. eCollection 2020.
7
IL-1α Processing, Signaling and Its Role in Cancer Progression.IL-1α 的加工、信号传递及其在癌症进展中的作用。
Cells. 2021 Jan 7;10(1):92. doi: 10.3390/cells10010092.
8
Rab GTPase Mediating Regulation of NALP3 in Colorectal Cancer.Rab GTPase 介导调控结直肠癌中的 NALP3。
Molecules. 2020 Oct 20;25(20):4834. doi: 10.3390/molecules25204834.
9
Antibiotics for cancer treatment: A double-edged sword.用于癌症治疗的抗生素:一把双刃剑。
J Cancer. 2020 Jun 28;11(17):5135-5149. doi: 10.7150/jca.47470. eCollection 2020.
10
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword.NLRP3 炎性小体在癌症中的激活:一把双刃剑。
Front Immunol. 2020 Jul 8;11:1444. doi: 10.3389/fimmu.2020.01444. eCollection 2020.